| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2023 , Vol 61 , Num 1
JNK and p53 inhibition in regenerationcompetent cells of nerve tissue: a novel approach for treatment of ethanol-induced neurodegeneration
1 Russian Academy of Sciences, Tomsk National Research Medical Center, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk, Russia
DOI :
10.23893/1307-2080.APS6104